Non-Small Cell Lung Cancer – Pipeline Review, H2 2013 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non-Small Cell Lung Cancer. Non-Small Cell Lung Cancer – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=112883.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/non-small-cell-lung-cancer-pipeline-review-h2-2013-market-report.html.
No comments:
Post a Comment